173 related articles for article (PubMed ID: 7731646)
1. Hormonal profiles in women with breast cancer.
Zumoff B
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):751-72. PubMed ID: 7731646
[TBL] [Abstract][Full Text] [Related]
2. Hormonal profiles in women with breast cancer (review).
Zumoff B
Anticancer Res; 1988; 8(4):627-36. PubMed ID: 3052248
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer: potentially predisposing and protecting factors. Role of pregnancy, lactation, and endocrine status.
Vorherr H; Messer RH
Am J Obstet Gynecol; 1978 Feb; 130(3):335-58. PubMed ID: 341711
[TBL] [Abstract][Full Text] [Related]
4. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women.
Sarkola T; Mäkisalo H; Fukunaga T; Eriksson CJ
Alcohol Clin Exp Res; 1999 Jun; 23(6):976-82. PubMed ID: 10397281
[TBL] [Abstract][Full Text] [Related]
5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and lactation in relation to breast cancer risk.
Vorherr H
Semin Perinatol; 1979 Jul; 3(3):299-311. PubMed ID: 392771
[TBL] [Abstract][Full Text] [Related]
7. Abnormal production of androgens in women with breast cancer.
Secreto G; Zumoff B
Anticancer Res; 1994; 14(5B):2113-7. PubMed ID: 7840509
[TBL] [Abstract][Full Text] [Related]
8. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
10. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
11. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
12. [Hormones and breast cancer. Current views].
Molinatti GM; Limone P
Minerva Med; 1982 Apr; 73(17):1047-53. PubMed ID: 6281687
[No Abstract] [Full Text] [Related]
13. Hormone alterations in breast cancer: examining the hypotheses.
Hindle WH
Medscape Womens Health; 1999; 4(1):4. PubMed ID: 10089557
[TBL] [Abstract][Full Text] [Related]
14. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
[TBL] [Abstract][Full Text] [Related]
15. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women.
Tworoger SS; Eliassen AH; Missmer SA; Baer H; Rich-Edwards J; Michels KB; Barbieri RL; Dowsett M; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2494-501. PubMed ID: 17164375
[TBL] [Abstract][Full Text] [Related]
16. Hormone profiles in hormone-dependent cancers.
Zumoff B; Fishman J; Bradlow HL; Hellman L
Cancer Res; 1975 Nov; 35(11 Pt. 2):3365-73. PubMed ID: 1104149
[TBL] [Abstract][Full Text] [Related]
17. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
Schover LR
Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
[TBL] [Abstract][Full Text] [Related]
18. A physiologic role for testosterone in limiting estrogenic stimulation of the breast.
Dimitrakakis C; Zhou J; Wang J; Belanger A; LaBrie F; Cheng C; Powell D; Bondy C
Menopause; 2003; 10(4):292-8. PubMed ID: 12851512
[TBL] [Abstract][Full Text] [Related]
19. Disordered nocturnal prolactin regulation in women with breast cancer.
Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
[TBL] [Abstract][Full Text] [Related]
20. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones.
Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE
Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
